Firms unite to develop drugs targeting protein homeostasis

Forma Therapeutics and Celgene will collaborate in the discovery, development and commercialization of drug candidates that can regulate protein homeostasis targets. Forma will get an upfront payment and as much as $200 million in research funding. In exchange, Celgene will get the rights to develop and market several drug candidates outside the U.S. Forma will keep the U.S. rights to the drugs arising from the collaboration.

View Full Article in:

Genetic Engineering & Biotechnology News · BioWorld (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Director, Site Quality Management
CareFusion
Palm Springs, CA